{
  "openalex_id": "W2514974106",
  "doi": "https://doi.org/10.18632/oncotarget.11814",
  "title": "Discovery and clinical introduction of first-in-class imipridone ONC201",
  "abstract": "// Joshua E. Allen 1 , C. Leah B. Kline 2 , Varun V. Prabhu 1 , Jessica Wagner 2 , Jo Ishizawa 3 , Neel Madhukar 4 , Avital Lev 2 , Marie Baumeister 2 , Lanlan Zhou 2 , Amriti Lulla 2 , Martin Stogniew 1 , Lee Schalop 1 , Cyril Benes 5,6 , Howard L. Kaufman 7 , Richard S. Pottorf 8 , B. Rao Nallaganchu 8 , Gary L. Olson 8 , Fahd Al-Mulla 9 , Madeleine Duvic 3 , Gen Sheng Wu 10 , David T. Dicker 2 , Mala K. Talekar 11 , Bora Lim 3 , Olivier Elemento 4 , Wolfgang Oster 1 , Joseph Bertino 7 , Keith Flaherty 5,6 , Michael L. Wang 3 , Gautam Borthakur 3 , Michael Andreeff 3 , Mark Stein 7 and Wafik S. El-Deiry 2 1 Oncoceutics, Inc., Philadelphia, PA, USA 2 Fox Chase Cancer Center, Philadelphia, PA, USA 3 University of Texas MD Anderson Cancer Center, Houston, TX, USA 4 Weill Cornell Medicine, New York, NY, USA 5 Massachusetts General Hospital, Boston, MA, USA 6 Harvard Medical School, Boston, MA, USA 7 Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA 8 Provid Pharmaceuticals, Monmouth Junction, NJ, USA 9 Kuwait University Medical School, Kuwait 10 Karmanos Cancer Institute, Detroit, MI, USA 11 The Children&rsquo;s Hospital of Philadelphia, Philadelphia, PA, USA Correspondence to: Wafik S. El-Deiry, email: // Keywords : ONC201, TIC10, integrated stress response, ATF4, DRD2 Received : August 23, 2016 Accepted : August 30, 2016 Published : September 01, 2016 Abstract ONC201 is the founding member of a novel class of anti-cancer compounds called imipridones that is currently in Phase II clinical trials in multiple advanced cancers. Since the discovery of ONC201 as a p53-independent inducer of TRAIL gene transcription, preclinical studies have determined that ONC201 has anti-proliferative and pro-apoptotic effects against a broad range of tumor cells but not normal cells. The mechanism of action of ONC201 involves engagement of PERK-independent activation of the integrated stress response, leading to tumor upregulation of DR5 and dual Akt/ERK inactivation, and consequent Foxo3a activation leading to upregulation of the death ligand TRAIL. ONC201 is orally active with infrequent dosing in animals models, causes sustained pharmacodynamic effects, and is not genotoxic. The first-in-human clinical trial of ONC201 in advanced aggressive refractory solid tumors confirmed that ONC201 is exceptionally well-tolerated and established the recommended phase II dose of 625 mg administered orally every three weeks defined by drug exposure comparable to efficacious levels in preclinical models. Clinical trials are evaluating the single agent efficacy of ONC201 in multiple solid tumors and hematological malignancies and exploring alternative dosing regimens. In addition, chemical analogs that have shown promise in other oncology indications are in pre-clinical development. In summary, the imipridone family that comprises ONC201 and its chemical analogs represent a new class of anti-cancer therapy with a unique mechanism of action being translated in ongoing clinical trials.",
  "authors": [
    {
      "display_name": "Joshua E. Allen",
      "id": "A5008547275",
      "orcid": "https://orcid.org/0000-0002-6835-1128",
      "institutions": [
        {
          "id": "I4210128844",
          "display_name": "Oncoceutics (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Joshua E. Allen"
    },
    {
      "display_name": "C. Leah B. Kline",
      "id": "A5007967797",
      "orcid": "https://orcid.org/0000-0001-7764-0119",
      "institutions": [
        {
          "id": "I1289437631",
          "display_name": "Fox Chase Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "C. Leah B. Kline"
    },
    {
      "display_name": "Varun V. Prabhu",
      "id": "A5056800304",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210128844",
          "display_name": "Oncoceutics (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Varun V. Prabhu"
    },
    {
      "display_name": "Jessica Wagner",
      "id": "A5039564965",
      "orcid": "https://orcid.org/0000-0003-2587-3310",
      "institutions": [
        {
          "id": "I1289437631",
          "display_name": "Fox Chase Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jessica Wagner"
    },
    {
      "display_name": "Jo Ishizawa",
      "id": "A5049134775",
      "orcid": "https://orcid.org/0000-0001-8566-7370",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jo Ishizawa"
    },
    {
      "display_name": "Neel S. Madhukar",
      "id": "A5068268768",
      "orcid": "https://orcid.org/0000-0002-2907-2062",
      "institutions": [
        {
          "id": "I4387153466",
          "display_name": "Weill Cornell Medicine",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I205783295",
          "display_name": "Cornell University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Neel Madhukar"
    },
    {
      "display_name": "Avital Lev",
      "id": "A5006632634",
      "orcid": "https://orcid.org/0000-0002-2127-7338",
      "institutions": [
        {
          "id": "I1289437631",
          "display_name": "Fox Chase Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Avital Lev"
    },
    {
      "display_name": "Marie Baumeister",
      "id": "A5073277885",
      "orcid": null,
      "institutions": [
        {
          "id": "I1289437631",
          "display_name": "Fox Chase Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Marie Baumeister"
    },
    {
      "display_name": "Lanlan Zhou",
      "id": "A5100674993",
      "orcid": "https://orcid.org/0000-0001-9471-9099",
      "institutions": [
        {
          "id": "I1289437631",
          "display_name": "Fox Chase Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Lanlan Zhou"
    },
    {
      "display_name": "Amriti R. Lulla",
      "id": "A5083321772",
      "orcid": "https://orcid.org/0000-0002-7085-5755",
      "institutions": [
        {
          "id": "I1289437631",
          "display_name": "Fox Chase Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Amriti Lulla"
    },
    {
      "display_name": "Martin Stogniew",
      "id": "A5055837818",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210128844",
          "display_name": "Oncoceutics (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Martin Stogniew"
    },
    {
      "display_name": "Lee Schalop",
      "id": "A5059799987",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210128844",
          "display_name": "Oncoceutics (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Lee Schalop"
    },
    {
      "display_name": "Cyril H. Benes",
      "id": "A5060699951",
      "orcid": "https://orcid.org/0000-0002-8751-9707",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Cyril Benes"
    },
    {
      "display_name": "Howard L. Kaufman",
      "id": "A5090739964",
      "orcid": "https://orcid.org/0000-0003-1131-004X",
      "institutions": [
        {
          "id": "I4390039325",
          "display_name": "Rutgers Cancer Institute of New Jersey",
          "country_code": null,
          "type": "healthcare"
        },
        {
          "id": "I102322142",
          "display_name": "Rutgers, The State University of New Jersey",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Howard L. Kaufman"
    },
    {
      "display_name": "Richard S. Pottorf",
      "id": "A5049900020",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210120562",
          "display_name": "Provid Pharmaceuticals (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Richard S. Pottorf"
    },
    {
      "display_name": "Bhaskara Rao Nallaganchu",
      "id": "A5072765418",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210120562",
          "display_name": "Provid Pharmaceuticals (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "B. Rao Nallaganchu"
    },
    {
      "display_name": "Gary L. Olson",
      "id": "A5065266616",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210120562",
          "display_name": "Provid Pharmaceuticals (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Gary L. Olson"
    },
    {
      "display_name": "Fahd Al‐Mulla",
      "id": "A5045720408",
      "orcid": "https://orcid.org/0000-0001-5409-3829",
      "institutions": [
        {
          "id": "I36721946",
          "display_name": "Kuwait University",
          "country_code": "KW",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Fahd Al-Mulla"
    },
    {
      "display_name": "Madeleine Duvic",
      "id": "A5030460763",
      "orcid": "https://orcid.org/0000-0002-8971-4565",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Madeleine Duvic"
    },
    {
      "display_name": "Gen Sheng Wu",
      "id": "A5059971077",
      "orcid": "https://orcid.org/0000-0001-8166-5474",
      "institutions": [
        {
          "id": "I4210090317",
          "display_name": "The Barbara Ann Karmanos Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Gen Sheng Wu"
    },
    {
      "display_name": "David T. Dicker",
      "id": "A5023976873",
      "orcid": "https://orcid.org/0000-0002-0610-8317",
      "institutions": [
        {
          "id": "I1289437631",
          "display_name": "Fox Chase Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "David T. Dicker"
    },
    {
      "display_name": "Mala K. Talekar",
      "id": "A5034307197",
      "orcid": "https://orcid.org/0000-0001-9084-3682",
      "institutions": [
        {
          "id": "I1335321130",
          "display_name": "Children's Hospital of Philadelphia",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Mala K. Talekar"
    },
    {
      "display_name": "Bora Lim",
      "id": "A5053893309",
      "orcid": "https://orcid.org/0000-0002-4182-6058",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Bora Lim"
    },
    {
      "display_name": "Olivier Elemento",
      "id": "A5061702711",
      "orcid": "https://orcid.org/0000-0002-8061-9617",
      "institutions": [
        {
          "id": "I205783295",
          "display_name": "Cornell University",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I4387153466",
          "display_name": "Weill Cornell Medicine",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Olivier Elemento"
    },
    {
      "display_name": "Wolfgang Oster",
      "id": "A5036916387",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210128844",
          "display_name": "Oncoceutics (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Wolfgang Oster"
    },
    {
      "display_name": "Joseph Bertino",
      "id": "A5085085138",
      "orcid": null,
      "institutions": [
        {
          "id": "I102322142",
          "display_name": "Rutgers, The State University of New Jersey",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I4390039325",
          "display_name": "Rutgers Cancer Institute of New Jersey",
          "country_code": null,
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Joseph Bertino"
    },
    {
      "display_name": "Keith T. Flaherty",
      "id": "A5023174631",
      "orcid": "https://orcid.org/0000-0002-3402-0478",
      "institutions": [
        {
          "id": "I4210087915",
          "display_name": "Massachusetts General Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Keith Flaherty"
    },
    {
      "display_name": "Michael Wang",
      "id": "A5100438316",
      "orcid": "https://orcid.org/0000-0001-9748-5486",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Michael L. Wang"
    },
    {
      "display_name": "Gautam Borthakur",
      "id": "A5055045706",
      "orcid": "https://orcid.org/0000-0001-7679-6453",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Gautam Borthakur"
    },
    {
      "display_name": "Michael Andreeff",
      "id": "A5079262854",
      "orcid": "https://orcid.org/0000-0002-1144-1958",
      "institutions": [
        {
          "id": "I1343551460",
          "display_name": "The University of Texas MD Anderson Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Michael Andreeff"
    },
    {
      "display_name": "Mark N. Stein",
      "id": "A5071773606",
      "orcid": "https://orcid.org/0000-0002-0853-3640",
      "institutions": [
        {
          "id": "I4390039325",
          "display_name": "Rutgers Cancer Institute of New Jersey",
          "country_code": null,
          "type": "healthcare"
        },
        {
          "id": "I102322142",
          "display_name": "Rutgers, The State University of New Jersey",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Mark Stein"
    },
    {
      "display_name": "Wafik S. El‐Deiry",
      "id": "A5075201353",
      "orcid": "https://orcid.org/0000-0002-9577-8266",
      "institutions": [
        {
          "id": "I1289437631",
          "display_name": "Fox Chase Cancer Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": true,
      "raw_author_name": "Wafik S. El-Deiry"
    }
  ],
  "publication_year": 2016,
  "publication_date": "2016-09-01",
  "type": "review",
  "cited_by_count": 143,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S126644158",
    "display_name": "Oncotarget",
    "issn_l": "1949-2553",
    "issn": [
      "1949-2553"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310316297"
  },
  "volume": "7",
  "issue": "45",
  "first_page": "74380",
  "last_page": "74392",
  "open_access": {
    "is_oa": true,
    "oa_status": "gold",
    "oa_url": "http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=11814&path%5B%5D=37396",
    "any_repository_has_fulltext": true
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.7320701
    },
    {
      "id": "C98274493",
      "display_name": "Pharmacology",
      "level": 1,
      "score": 0.58388424
    },
    {
      "id": "C535046627",
      "display_name": "Clinical trial",
      "level": 2,
      "score": 0.55375534
    },
    {
      "id": "C127561419",
      "display_name": "Downregulation and upregulation",
      "level": 3,
      "score": 0.5224049
    },
    {
      "id": "C2777288759",
      "display_name": "Dosing",
      "level": 2,
      "score": 0.49686173
    },
    {
      "id": "C2779638656",
      "display_name": "Integrated stress response",
      "level": 5,
      "score": 0.4770595
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.46278104
    },
    {
      "id": "C2780035454",
      "display_name": "Drug",
      "level": 2,
      "score": 0.44289815
    },
    {
      "id": "C2776120743",
      "display_name": "Mechanism of action",
      "level": 3,
      "score": 0.42190698
    },
    {
      "id": "C502942594",
      "display_name": "Cancer research",
      "level": 1,
      "score": 0.3451348
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.24778602
    },
    {
      "id": "C202751555",
      "display_name": "In vitro",
      "level": 2,
      "score": 0.17534369
    },
    {
      "id": "C185592680",
      "display_name": "Chemistry",
      "level": 0,
      "score": 0.12679708
    },
    {
      "id": "C55493867",
      "display_name": "Biochemistry",
      "level": 1,
      "score": 0.0
    },
    {
      "id": "C149364088",
      "display_name": "Translation (biology)",
      "level": 4,
      "score": 0.0
    },
    {
      "id": "C105580179",
      "display_name": "Messenger RNA",
      "level": 3,
      "score": 0.0
    },
    {
      "id": "C104317684",
      "display_name": "Gene",
      "level": 2,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T11914",
      "display_name": "PARP inhibition in cancer therapy",
      "score": 0.9998
    },
    {
      "id": "T11845",
      "display_name": "Cancer therapeutics and mechanisms",
      "score": 0.9997
    },
    {
      "id": "T10294",
      "display_name": "Cell death mechanisms and regulation",
      "score": 0.9991
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.18632/oncotarget.11814",
  "pdf_url": "http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=11814&path%5B%5D=37396",
  "retrieved_date": "2025-07-30T15:58:50.617517",
  "source_database": "OpenAlex"
}